Citation & Authors
J Am Acad Dermatol. 2024;91(5):889-895.
ABSTRACT · RESEARCH SUMMARY
Research summary
The TriNetX study compared incident psoriatic arthritis in adults with psoriasis receiving IL-23 or IL-12/23 inhibitors. Cumulative incidence did not differ significantly between groups (P=0.812), consistent with the Kaplan–Meier analysis. Although the incidence was numerically lower in the IL-23 group, superiority over IL-12/23 inhibitors has not been established; longer follow-up is needed.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
